ADMA BIOLOGICS, INC. Uncategorized Contracts & Agreements
22 Contracts & Agreements
- Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 24, 2022)
- Open Market Sale AgreementSM, dated May 28, 2021, by and between ADMA Biologics, Inc. and Jefferies LLC (Filed With SEC on May 28, 2021)
- Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 25, 2021)
- Amendment No. 2 to Sale Agreement, dated as of February 3, 2021 (Filed With SEC on February 3, 2021)
- Amendment to Open Market Sale AgreementSM, dated November 5, 2020, by and between ADMA Biologics, Inc. and Jefferies LLC (Filed With SEC on November 5, 2020)
- Open Market Sale AgreementSM, dated August 5, 2020, by and between ADMA Biologics, Inc. and Jefferies LLC (Filed With SEC on August 5, 2020)
- Agreement to Transfer Land, dated as of July 20, 2018, by and among Biotest Real Estate Corp., Biotest AG, Biotest Pharmaceuticals Corporation, ADMA BioManufacturing, LLC and ADMA... (Filed With SEC on July 24, 2018)
- Amendment #3 to the Manufacturing Agreement, effective as of December 21, 2017, by and between ADMA BioManufacturing, LLC and Sanofi Pasteur S.A (Filed With SEC on March 29, 2018)
- Amendment #2 to the Manufacturing Agreement, effective as of August 1, 2016, by and between ADMA BioManufacturing, LLC (as successor-in-interest to Biotest Pharmaceuticals... (Filed With SEC on March 29, 2018)
- Manufacturing Agreement, dated as of September 30, 2011, by and between ADMA BioManufacturing, LLC (as successor-in-interest to Biotest Pharmaceuticals Corporation) and Sanofi... (Filed With SEC on March 29, 2018)
- FOURTH AMENDMENT TO PLASMAPURCHASE AGREEMENT (Filed With SEC on August 11, 2017)
- FIRST AMENDMENT TO LICENSEAGREEMENT (Filed With SEC on August 11, 2017)
- PURCHASEAGREEMENT (Filed With SEC on August 11, 2017)
- PLASMAPURCHASE AGREEMENT NORMAL SOURCE PLASMA PURCHASEFROM BPC TO ADMA (Filed With SEC on August 11, 2017)
- TRANSITIONSERVICES AGREEMENT by and between ADMA BIOMANUFACTURING,LLC and BIOTEST PHARMACEUTICALSCORPORATION Dated as ofJune 6, 2017 (Filed With SEC on August 11, 2017)
- STOCKHOLDERS AGREEMENT by and among ADMA Biologics, Inc., Biotest Pharmaceuticals Corporation and Such other Persons who become party heretopursuant to Section 4.1(c)... (Filed With SEC on June 12, 2017)
- Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 24b-2 under the... (Filed With SEC on March 23, 2016)
- Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 24b-2 under the... (Filed With SEC on March 23, 2016)
- 1,225,000Shares* (Filed With SEC on March 13, 2015)
- EQUITY RIGHTS LETTER (Filed With SEC on February 11, 2013)
- ADMA Biologics, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portions denoted by [***] (Filed With SEC on June 22, 2012)
- FORM OF LOCK-UP AGREEMENT (Filed With SEC on February 13, 2012)
